Skip to main content

ACOPLAMIENTO FUNCIONAL ENTRE LA TRANSCRIPCION Y EL SPLICING

BFU2014-54660-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication

Targeting Splicing in the Treatment of Human Disease

  • Suñé-Pou, Marc
  • Prieto-Sánchez, Silvia
  • Boyero-Corral, Sofía
  • Moreno-Castro, Cristina
  • El Yousfi, Younes
  • Suñé-Negre, Josep Mª
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splicing regulation have led to the development of new tools for manipulating splicing for therapeutic purposes. Several tools, including antisense oligonucleotides and <i>trans</i>-splicing, have been developed to target and alter splicing to correct misregulated gene expression or to modulate transcript isoform levels. At present, deregulated AS is recognized as an important area for therapeutic intervention. Here, we summarize the major hallmarks of the splicing process, the clinical implications that arise from alterations in this process, and the current tools that can be used to deliver, target, and correct deficiencies of this key pre-mRNA processing event., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to Carlos Suñé and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) and the Andalusian Government (Excellence Project CTS-6587) to Cristina Hernández-Munain Support from the European Region Development Fund (ERDF (FEDER)) is also acknowledged. We apologize to all researchers whose papers pertinent to this article we failed to cite, We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Transcriptional elongation regulator 1 affects transcription and splicing of genes associated with cellular morphology and cytoskeleton dynamics and is required for neurite outgrowth in neuroblastoma cells and primary neuronal cultures

  • Muñoz-Cobo, Juan Pablo
  • Sánchez-Hernández, Noemí
  • Gutiérrez, Sara
  • El Yousfi, Younes
  • Montes, Marta
  • Gallego, Carme
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
TCERG1 is a highly conserved human protein implicated in interactions with the transcriptional and splicing machinery that is associated with neurodegenerative disorders. Biochemical, neuropathological, and genetic evidence suggests an important role for TCERG1 in Huntington’s disease (HD) pathogenesis. At present, the molecular mechanism underlying TCERG1-mediated neuronal effects is unknown. Here, we show that TCERG1 depletion led to widespread alterations in mRNA processing that affected different types of alternative transcriptional or splicing events, indicating that TCERG1 plays a broad role in the regulation of alternative splicing. We observed considerable changes in the transcription and alternative splicing patterns of genes involved in cytoskeleton dynamics and neurite outgrowth. Accordingly, TCERG1 depletion in the neuroblastoma SH-SY5Y cell line and primary mouse neurons affected morphogenesis and resulted in reduced dendritic outgrowth, with a major effect on dendrite ramification and branching complexity. These defects could be rescued by ectopic expression of TCERG1. Our results indicate that TCERG1 affects expression of multiple mRNAs involved in neuron projection development, whose misregulation may be involved in TCERG1-linked neurological disorders., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014–54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2013–44660-R) and the Andalusian Government (Excellence Project CTS-6587) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]), is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy

  • Suñé-Pou, Marc
  • Prieto-Sánchez, Silvia
  • El Yousfi, Younes
  • Boyero-Corral, Sofía
  • Nardi-Ricart, Anna
  • Nofrerias-Roig, Isaac
  • Pérez-Lozano, Pilar
  • García-Montoya, Encarna
  • Minarro-Carmona, Montserrat
  • Ramón Tico, Josep
  • Suñé-Negre, Josep Mª
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Background: Cationic solid lipid nanoparticles (SLNs) have been given considerable attention for therapeutic nucleic acid delivery owing to their advantages over viral and other nanoparticle delivery systems. However, poor delivery efficiency and complex formulations hinder the clinical translation of SLNs. Aim: The aim of this study was to formulate and characterize SLNs incorporating the cholesterol derivative cholesteryl oleate to produce SLN-nucleic acid complexes with reduced cytotoxicity and more efficient cellular uptake. Methods: Five cholesteryl oleate-containing formulations were prepared. Laser diffraction and laser Doppler microelectrophoresis were used to evaluate particle size and zeta potential, respectively. Nanoparticle morphology was analyzed using electron microscopy. Cytotoxicity and cellular uptake of lipoplexes were evaluated using flow cytometry and fluorescence microscopy. The gene inhibition capacity of the lipoplexes was assessed using siRNAs to block constitutive luciferase expression. Results: We obtained nanoparticles with a mean diameter of approximately 150-200 nm in size and zeta potential values of 25-40 mV. SLN formulations with intermediate concentrations of cholesteryl oleate exhibited good stability and spherical structures with no aggregation. No cell toxicity of any reference SLN was observed. Finally, cellular uptake experiments with DNA- and RNA-SLNs were performed to select one reference with superior transient transfection efficiency that significantly decreased gene activity upon siRNA complexation. Conclusion: The results indicate that cholesteryl oleate-loaded SLNs are a safe and effective platform for nonviral nucleic acid delivery., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. We thank Jose Alcami and Mayte Coiras (National Microbiology Center, Majadahonda, Madrid, Spain) for the TZM-bl cells. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to CS and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to CHM. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. MSP was supported by a fellowship from the Spanish Ministry of Education (FPU Program [Training Program for Academic Staff])., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Improved formulation of cationic solid lipid nanoparticles displays cellular uptake and biological activity of nucleic acids

  • Fabregas, Anna
  • Prieto-Sánchez, Silvia
  • Suñé-Pou, Marc
  • Boyero-Corral, Sofía
  • Ramón Tico, Josep
  • García-Montoya, Encarna
  • Pérez-Lozano, Pilar
  • Minarro, Montserrat
  • Suñé-Negre, Josep Mª
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Non-viral delivery using cationic solid lipid nanoparticles (SLNs) represents a useful strategy to introduce large DNA and RNA molecules to target cells. A careful selection of components and their amounts is critical to improve transfection efficiency. In this work, a selected and optimized formulation of SLNs was used to efficiently transfect circular DNA and linear RNA molecules into cells. We characterized the main physicochemical characteristics and binding capabilities of these SLNs and show that they deliver DNA and RNA molecules into cells where they display full bioactivity at nontoxic concentrations using fluorescence-and luminescence-based methodologies. Hence, we established a novel and simple SLN formulation as a powerful tool for future therapeutic use. (C) 2016 Elsevier B.V. All rights reserved., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2013-44660-R) and the Andalusian Government (Excellence Project CTS-6587) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]), is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Targeting proteins to RNA transcription and processing sites within the nucleus, Conferencia: 1st International Caparica Conference in Splicing (SPLICING)

  • Sánchez-Hernández, Noemí
  • Prieto-Sánchez, Silvia
  • Moreno-Castro, Cristina
  • Muñoz-Cobo, Juan Pablo
  • El Yousfi, Younes
  • Boyero-Corral, Sofía
  • Suñé-Pou, Marc
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
Conferencia: 1st International Caparica Conference in Splicing (SPLICING) Ubicación: Lisbon, PORTUGAL Fecha: SEP 12-14, 2016 Patrocinador(es):BRUKER; Elsevier; ThermoFisher Sci; RNA Soc; STAB Vida, Studies of the spatial organization of the highly compartmentalized eukaryotic nucleus and dynamics of transcription and RNA processing within it are fundamental for fully understanding how gene expression is regulated in the cell. Although some progress has been made in deciphering the functional consequences of this complex network of interacting molecules in the context of nuclear organization, how proteins and RNA move in the nucleus and how the transcription and RNA processing machineries find their targets are important questions that remain largely unexplored. Here, we review major hallmarks and novel insights regarding the movement of RNA and proteins in the context of nuclear organization as well as the mechanisms by which the proteins involved in RNA processing localize to specific nuclear compartments., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (Excellence Project B10-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (grant number BFU2016-79699-P) to C.H.M. Support from the European Region Development Fund (ERDF [FEDER]) is also acknowledged. We apologize to all researchers with papers pertinent to this article whose work we failed to cite., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drosophila Prp40 localizes to the histone locus body and regulates gene transcription and development

  • Prieto-Sánchez, Silvia
  • Moreno-Castro, Cristina
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
In eukaryotes, a large amount of histones need to be synthesized during the S phase of the cell cycle to package newly synthesized DNA into chromatin. The transcription and 3' end processing of histone pre-mRNAs are controlled by the histone locus body (HLB), which is assembled on the shared promoter for H3 and H4 Here, we identified the Drosophila Prp40 pre-mRNA processing factor (dPrp40, annotated as CG3542) as a novel HLB component. We showed that dPrp40 is essential for Drosophila development, with functionally conserved activity in vertebrates and invertebrates. We observed that dPrp40 is fundamental in endocycling cells, highlighting a role for this factor in mediating replication efficiency in vivo The depletion of dPrp40 from fly cells inhibited the transcription, but not the 3' end processing, of histone mRNA in a H3- and H4-promoter-dependent manner. Our results establish that dPrp40 is an essential protein for Drosophila development that can localize to the HLB and might participate in histone mRNA biosynthesis., This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; BFU2014-54660-R and BFU2017-89179-R) and the Andalusian Government (BIO-2515/2012) to C.S. and from the Spanish Ministry of Economy and Competitiveness (BFU2016-79699-P) to C.H.M. S.P.-S. was supported by a contract from the Spanish Ministry of Economy and Competitiveness (Juan de la Cierva Program). Support from the European Region Development Fund [ERDF (FEDER)] is also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prp40 and early events in splice site definition

  • Becerra, Soraya
  • Andrés-León, Eduardo
  • Prieto-Sánchez, Silvia
  • Hernández-Munaín, Cristina
  • Suñé, Carlos
The alternative splicing (AS) of precursor messenger RNA (pre-mRNA) is a tightly regulated process through which introns are removed to leave the resulting exons in the mRNA appropriately aligned and ligated. The AS of pre-mRNA is a key mechanism for increasing the complexity of proteins encoded in the genome. In humans, more than 90% of genes undergo AS, underscoring the importance of this process in RNA biogenesis. As such, AS misregulation underlies multiple human diseases. The splicing reaction is catalyzed by the spliceosome, a highly dynamic complex that assembles at or near the intron/exon boundaries and undergoes sequential conformational and compositional changes during splicing. The initial recognition of splice sites defines the exons that are going to be removed, which is a critical step in the highly regulated splicing process. Although the available lines of evidence are increasing, the molecular mechanisms governing AS, including the initial interactions occurring at intron/exon boundaries, and the factors that modulate these critical connections by functioning as a scaffold for active-site RNAs or proteins, remain poorly understood. In this review, we summarize the major hallmarks of the initial steps in the splicing process and the role of auxiliary factors that contribute to the assembly of the spliceosomal complex. We also discuss the role of the essential yeast Prp40 protein and its mammalian homologs in the specificity of this pre-mRNA processing event. In addition, we provide the first exhaustive phylogenetic analysis of the molecular evolution of Prp40 family members. WIREs RNA 2016, 7:17-32. doi: 10.1002/wrna.1312 For further resources related to this article, please visit the WIREs website., We are grateful to many colleagues for their helpful suggestions, critical discussions, and comments. This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2014-54660-R) and the Andalusian Government (BIO-2515/2012) to C.S., and by grants from the Spanish Ministry of Economy and Competitiveness (grant number BFU2013-44660-R) and the Andalusian Government (Excellence Project CTS-6587) to C.H.M. Support from the European Region Development Fund, ERDF (FEDER), is also acknowledged., Peer reviewed